Anti-tumor activity of olaparib, a poly (ADP-ribose) polymerase (PARP) inhibitor, in cultured endometrial carcinoma cells
Aki Miyasaka(The University of Tokyo), Tomoyuki Fujii(The University of Tokyo)
Cited by 63
Related Papers
Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer
|Oncotarget|2017|67
Antitumor Activity and Induction of TP53-Dependent Apoptosis toward Ovarian Clear Cell Adenocarcinoma by the Dual PI3K/mTOR Inhibitor DS-7423
|PLoS ONE|2014|51
Putative tumor suppression function of SIRT6 in endometrial cancer
|FEBS Letters|2015|36